CB Scientific Statistics
Total Valuation
CB Scientific has a market cap or net worth of 6.50 million.
Market Cap | 6.50M |
Enterprise Value | n/a |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
CB Scientific has 163.67 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 163.67M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 129.00 |
PB Ratio | -4.71 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.03
Current Ratio | 0.03 |
Quick Ratio | 0.01 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 54.21% |
Revenue Per Employee | 10,074 |
Profits Per Employee | -128,109 |
Employee Count | 5 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.33% in the last 52 weeks. The beta is 1.63, so CB Scientific's price volatility has been higher than the market average.
Beta (5Y) | 1.63 |
52-Week Price Change | -33.33% |
50-Day Moving Average | 0.04 |
200-Day Moving Average | 0.06 |
Relative Strength Index (RSI) | 50.59 |
Average Volume (20 Days) | 53,588 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.28 |
Income Statement
In the last 12 months, CB Scientific had revenue of 50,370 and -640,547 in losses. Loss per share was -0.01.
Revenue | 50,370 |
Gross Profit | 27,373 |
Operating Income | -748,497 |
Pretax Income | -640,547 |
Net Income | -640,547 |
EBITDA | n/a |
EBIT | -748,497 |
Loss Per Share | -0.01 |
Balance Sheet
The company has 6,820 in cash and n/a in debt, giving a net cash position of 6,820 or 0.00 per share.
Cash & Cash Equivalents | 6,820 |
Total Debt | n/a |
Net Cash | 6,820 |
Net Cash Per Share | 0.00 |
Equity (Book Value) | -1.38M |
Book Value Per Share | -0.02 |
Working Capital | -1.40M |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | 54.34% |
Operating Margin | -1,486.00% |
Pretax Margin | -1,271.68% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CB Scientific does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -9.86% |
FCF Yield | n/a |
Stock Splits
The last stock split was on February 16, 2016. It was a reverse split with a ratio of 0.0133333.
Last Split Date | Feb 16, 2016 |
Split Type | Reverse |
Split Ratio | 0.0133333 |
Scores
CB Scientific has an Altman Z-Score of -100.66. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -100.66 |
Piotroski F-Score | n/a |